HighGravityData
Companies / Centene / Filing

Centene — Oct 29, 2025 release

Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001071739-25-000185
Open on SEC.gov ↗
Showing in the filing
Expected full year adjusted effective tax rate
“20-21%”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 3
Expected full year adjusted effective tax rate for FY2025
“20-21%”
GAAP forecast diluted loss per share for FY2025
“not to exceed $(12.85)”
Adjusted diluted EPS forecast for FY2025
“at least $2.00”
Exhibit 99.1 · the passage around this item
… earlier in the release
f $0.50 -- • Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%. • $6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025. • Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the first and second quarters of 2025 from a large state. • Commercial and Medicare segment results in line with expectations. • Increases 2025 full year adjusted diluted EPS forecast by $0.25 to at least $2.00. ST. LOUIS, October 29, 2025 -- Centene Corporation (NYSE: CNC) (the Company) announced today its financial results for the third quarter ended September 30, 2025. In summary, the 2025 third quarter results were as follows: Total revenues (in millions) $ 49,690  Premium and service revenues (in millions) $ 44,898  Health benefits ratio 92.7  % SG&A expense ratio 7.0  % Adjusted SG&A expense ratio (1) 7.0  % GAAP diluted loss per share $ (13.50) Adjusted diluted earnings per share (1) $ 0.50  Total cash flow provided by operations (in millions) $ 1,356  (1) Represents a non-GAAP financ
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.